Back

Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Oral anticoagulation in patients with atrial fibrillation Anticoagulants ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Mia Ravn Jacobsen

Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Ischemic and non-ischemic stroke reported in DOAC treated patients with atrial fibrillation and levetiracetam drug interaction: a real-world study
Doctor M. Abou Kaoud (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Optimal adherence threshold to non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation to reduce the risk of thromboembolism and death
Mr M. Grymonprez (Gent, BE)
Abstract Slides Video
Presentation thumbnail
Clinical impact of switching or continuation of apixaban or rivaroxaban among patients with non-valvular atrial fibrillation
Doctor S. Deitelzweig (New Orleans, US)
Abstract Slides Video
Presentation thumbnail
Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin
Doctor S. Patel (Boston, US)
Abstract Slides Video
Presentation thumbnail
Comparisons of effectiveness and safety between different dosage strategy in patients with atrial fibrillation treated with rivaroxaban: a systemic review and meta-analysis
Doctor T. Chao (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Oral anticoagulation in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Anticoagulant monotherapy versus anticoagulant therapy in combination with single antiplatelet agent in patients after coronary artery bypass grafting - analysis of real-world data
thumbnail
Congress Presentation
Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study
thumbnail
Congress Presentation
Temporal trends in antithrombotic therapy following transcatheter aortic valve implantation in denmark

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources